Unknown

Dataset Information

Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial.


ABSTRACT:

SUBMITTER: Blay JY 

PROVIDER: S-EPMC8383051 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature